Search International and National Patent Collections
|1. (WO2017201579) ARTHROGENIC ALPHAVIRUS VACCINE|
|Title:||ARTHROGENIC ALPHAVIRUS VACCINE|
The invention relates to a vaccine comprising live attenuated recombinant alphavirus comprising mutated capsid protein. The invention also relates to a method of preventing a subject from contracting an alphaviral infection that would otherwise produce clinical signs of disease. In an embodiment the mutated capsid protein is Chikungunya virus (CHIKV) capsid protein having a mutated nucleolar localisation signal/sequence (NoLS), preferably the mutant NLS 101/95.